We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTI icon
3201
W&T Offshore
WTI
$555M
$46K ﹤0.01%
12,860
-4,165
-24% -$12.9K
TAST
3202
DELISTED
Carrols Restaurant Group, Inc.
TAST
$46K ﹤0.01%
7,806
+705
+10% +$4.6K
USWS
3203
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$46K ﹤0.01%
2,112
+1,408
+200% +$36.5K
APTS
3204
DELISTED
Preferred Apartment Communities, Inc.
APTS
$46K ﹤0.01%
4,660
-5,374
-54% -$45.7K
CALA
3205
DELISTED
Calithera Biosciences, Inc
CALA
$46K ﹤0.01%
953
-166
-15% -$9.66K
MCF
3206
DELISTED
Contango Oil & Gas Co.
MCF
$46K ﹤0.01%
11,779
+236
+2% +$906
AUDC icon
3207
AudioCodes
AUDC
$253M
$45K ﹤0.01%
1,654
+376
+29% +$11.2K
AVIR icon
3208
Atea Pharmaceuticals
AVIR
$411M
$45K ﹤0.01%
729
+397
+120% +$26.8K
BCLI
3209
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$45K ﹤0.01%
787
+498
+172% +$37.6K
CCBG icon
3210
Capital City Bank Group
CCBG
$898M
$45K ﹤0.01%
1,726
-1,647
-49% -$41.8K
CENT icon
3211
Central Garden & Pet Co
CENT
$2.74B
$45K ﹤0.01%
978
-2,913
-75% -$110K
CTBI icon
3212
Community Trust Bancorp
CTBI
$1.43B
$45K ﹤0.01%
1,023
-283
-22% -$11.6K
ESSA
3213
DELISTED
ESSA Bancorp
ESSA
$45K ﹤0.01%
2,790
-989
-26% -$15.6K
FSM icon
3214
Fortuna Silver Mines
FSM
$3.15B
$45K ﹤0.01%
7,029
-31,663
-82% -$238K
HBCP icon
3215
Home Bancorp
HBCP
$569M
$45K ﹤0.01%
1,233
-1,088
-47% -$35.7K
HCM icon
3216
HUTCHMED
HCM
$2.1B
$45K ﹤0.01%
1,578
-1,195
-43% -$38.1K
IESC icon
3217
IES Holdings
IESC
$15.1B
$45K ﹤0.01%
887
-1,465
-62% -$70.5K
NEXT icon
3218
NextDecade
NEXT
$1.88B
$45K ﹤0.01%
17,033
+8,601
+102% +$19.1K
SINT icon
3219
SiNtx Technologies
SINT
$10.4M
$45K ﹤0.01%
+1
New +$41.9K
SMLF icon
3220
iShares US Small Cap Equity Factor ETF
SMLF
$4.32B
$45K ﹤0.01%
849
-643
-43% -$32.5K
TPB icon
3221
Turning Point Brands
TPB
$1.74B
$45K ﹤0.01%
860
-575
-40% -$28.7K
UWM icon
3222
ProShares Ultra Russell2000
UWM
$250M
$45K ﹤0.01%
800
-61,104
-99% -$3.37M
VXUS icon
3223
Vanguard Total International Stock ETF
VXUS
$164B
$45K ﹤0.01%
725
+128
+21% +$8.03K
TCON
3224
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$45K ﹤0.01%
274
-304
-53% -$58.5K
PLXP
3225
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$45K ﹤0.01%
5,012
+4,574
+1,044% +$33.4K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.